Catalyst Funds Management Pty Ltd
Position in CTKB — Cytek Biosciences, Inc.
CIK 1896150
SYDNEY NSW, C3
Position in CTKB
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$276,875
+$261,809 QoQ
Shares Held
62,500
+2214.8% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#63
of 154 holders
Holding Since
Mar 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTKB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Catalyst Funds Management Pty Ltd holds $6,305,652 across 14 Medical Devices names. CTKB ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
32,301 | $2,930,992 | |
| 2 | SYK |
Stryker Corp
|
2,680 | $843,771 | |
| 3 | BSX |
Boston Scientific Corp
|
8,500 | $362,780 | |
| 4 | EW |
Edwards Lifesciences Corp
|
3,900 | $352,794 | |
| 5 | PEN |
Penumbra Inc
|
1,101 | $347,640 | |
| 6 | PODD |
Insulet Corp
|
2,101 | $319,877 | |
| 7 | CTKB |
Cytek Biosciences, Inc.
This page
|
62,500 | $276,875 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
3,000 | $258,270 |
All Filings in CTKB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $276,875 | 62,500 | Shares | Sole | 2026-08-10 | |
| 2024-06-30 | $15,066 | 2,700 | Shares | Sole | 2024-12-18 | |
| 2024-03-31 | $2,013 | 300 | Shares | Sole | 2024-12-05 | |
| No filing history on record for this holder in this stock. | ||||||